REED JOHN C
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to REED JOHN C. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| JNJ | EVP, Innovative Medicine, R&D | Sale | 21,721 | $192.71 | $4,185,854 | Oct 17, 2025 |
| JNJ | EVP, Innovative Medicine, R&D | Sale | 19,137 | $163.55 | $3,129,856 | Jul 17, 2025 |
| JNJ | EVP, Innovative Medicine, R&D | Tax Withholding | 11,002 | $156.31 | $1,719,723 | May 1, 2025 |
| JNJ | EVP, Innovative Medicine, R&D | Option Exercise | 1,350 | — | — | Feb 18, 2025 |
| JNJ | EVP, Innovative Medicine, R&D | Tax Withholding | 10,984 | $144.59 | $1,588,177 | May 1, 2024 |
| JNJ | EVP, Innovative Medicine, R&D | Tax Withholding | 10,984 | $144.59 | $1,588,177 | May 1, 2024 |
| IONS | Option Exercise | 4,900 | $5.17 | $25,333 | Sep 6, 2012 | |
| IONS | Option Exercise | 10,000 | $3.95 | $39,500 | Jul 9, 2012 | |
| IONS | Option Exercise | 10,000 | $8.15 | $81,500 | Jun 22, 2012 | |
| 0000897075 | Purchase | 3,846 | $6.50 | $24,999 | Oct 2, 2008 | |
| 0000897075 | Purchase | 25,000 | $6.50 | $162,500 | Oct 2, 2008 |